Kyung Hee Mi Korean Medicine Clinic, Seoul, South Korea.
Korean Medicine Clinical Trial Center, Korean Medicine Hospital, Kyung Hee University, Seoul, South Korea.
J Altern Complement Med. 2020 Dec;26(12):1176-1181. doi: 10.1089/acm.2020.0121. Epub 2020 Sep 15.
The clinical course of the third, fourth, and sixth cranial nerve palsies varies according to etiology and onset. The effects of in Korean patients with cranial nerve palsy and paralytic diplopia were assessed. This is a retrospective observational study. The study was conducted in a Korean Medicine clinic in Seoul, Korea. Subjects were 569 patients with cranial nerve palsy and diplopia who received in 2009-2018. The patients received herbal decoction, , for 4 weeks. The baseline characteristics, including onset, etiology, type of paralysis, and deviation angle, were collected. Patients whose diplopia resolved were classified as completely recovered. Potential factors affecting the clinical effectiveness of for this condition were explored. The rate and duration of complete recovery were narratively analyzed and compared with previous reports. Sixth cranial nerve palsy was the most common type of paralysis ( = 311, 55%) and undetermined origin was the most frequent etiology ( = 281, 49%). The complete recovery rate was higher in patients who started treatment within 12 weeks of onset (95%, 503/532) than in those who started treatment later (19%, 7/37). In 532 patients who started treatment within 12 weeks of onset, the complete recovery rate of patients with vascular origin (98%, 122/124), other diseases (97%, 94/97), and undetermined etiology (96%, 252/263) was statistically high compared with those of traumatic origin (73%, 35/48, < 0.05). The average treatment duration in the complete recovery group ( = 510) was 9.3 weeks. The treatment duration was correlated with the increase of deviation angle in all three types of cranial nerve palsies. Sixth cranial nerve palsy and undetermined etiology were common. There is an association between recovery of diplopia and the administration of when started within 12 weeks of onset. Results of the study need to be interpreted cautiously due to the limited nature of narrative retrospective analysis.
第三、四、六对颅神经麻痹的临床病程因病因和发病时间而异。评估 在韩国颅神经麻痹和麻痹性复视患者中的作用。这是一项回顾性观察研究。该研究在韩国首尔的一家韩国医学诊所进行。共有 569 例颅神经麻痹和复视患者于 2009 年至 2018 年接受 治疗。患者接受草药汤 治疗 4 周。收集了基线特征,包括发病时间、病因、麻痹类型和偏斜角度。将复视缓解的患者归类为完全恢复。探讨了影响该疾病 治疗效果的潜在因素。通过叙述性分析评估了完全恢复的比率和持续时间,并与以前的报告进行了比较。第六对颅神经麻痹是最常见的麻痹类型( = 311,55%),未确定病因是最常见的病因( = 281,49%)。发病后 12 周内开始治疗的患者(95%,503/532)完全恢复率高于发病后开始治疗的患者(19%,7/37)。在 532 例发病后 12 周内开始治疗的患者中,血管性病因(98%,122/124)、其他疾病(97%,94/97)和未确定病因(96%,252/263)的完全恢复率明显高于外伤性病因(73%,35/48, < 0.05)。完全恢复组( = 510)的平均治疗持续时间为 9.3 周。在所有三种类型的颅神经麻痹中,治疗持续时间与偏斜角度的增加呈正相关。第六对颅神经麻痹和未确定病因较为常见。发病后 12 周内开始治疗与复视恢复之间存在关联。由于叙述性回顾性分析的局限性,研究结果需要谨慎解释。